Skip to main content
Equibles

DEUTSCHE BANK AG\

Bank

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 948046 FRANKFURT AM MAIN, 2M
Back to SPRY Full portfolio

Position in SPRY

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$527,585
+$90,023 QoQ
Shares Held
65,866
+20.9% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#71
of 208 holders
Holding Since
Dec 2020
17 quarters on record
Voting authority Sole 2% Shared 0% None 98%

Common Shares in SPRY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. SPRY ranks #177 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,579,110 $784,391,303
2 REGN
Regeneron Pharmaceuticals, Inc.
 518,409 $323,248,743
3 ALNY
Alnylam Pharmaceuticals, Inc.
 815,400 $245,459,858
4 RVMD
Revolution Medicines, Inc.
 888,019 $166,308,196
5 RPRX
Royalty Pharma plc
 2,717,951 $152,395,510
6 INCY
Incyte Corp
 1,262,988 $143,172,312
7 ARGX
Argenx SE
 137,335 $127,415,291
8 LGND
Ligand Pharmaceuticals Inc
 249,611 $78,899,539

All Filings in SPRY

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $527,585 65,866
2026-03-31 $437,562 54,491
2025-12-31 $567,668 48,727
2025-09-30 $421,606 41,951
2025-06-30 $645,876 37,013
2025-03-31 $491,915 39,103
2024-12-31 $457,626 43,377
2024-09-30 $417,208 28,773
2024-06-30 $176,888 20,786
2024-03-31 $150,683 14,744
2023-12-31 $83,580 15,252
2022-03-31 $39,101 11,140
2021-12-31 $82,970 12,458
2021-09-30 $117,764 11,800
2021-06-30 $239,150 7,742
2021-03-31 $537,957 12,330
2020-12-31 $231,700 5,000